Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-25-118848·Enveric Biosciences, Inc.
Schedule 13G ownership disclosure
ENVERIC BIOSCIENCES INC
Common Stock, $0.01 par value per share · CUSIP: 29405E505
Event date: 2025-12-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Northstrive Fund II LP
Shares: 25,915.00 · Class: 4.34%
- Braeden Lichti
Shares: 29,920.00 · Class: 5.01%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-118848
- Form type
- SCHEDULE 13G
- Filer
- Enveric Biosciences, Inc.
- CIK
- CIK 890821
- Filed
- Dec 05, 2025
- Reporting period
- Dec 03, 2025
- Description
- Schedule 13G beneficial ownership